CD19 and B-cell chronic lymphocytic leukemia: Subsequently, in 2010, Pekarsky and colleagues generated transgenic mice over-expressing miR-29 in B-cells and showed that the immunophenotypic profile of spleen lymphocytes from transgenic mice had increased populations of CD5+CD19+IgM+ B-cells, a characteristic of CLL.